BioCatalystWatch
OLMAWorkspace / OLMA / OverviewCompany library
Olema Pharmaceuticals, Inc. logo

Olema Pharmaceuticals, Inc.

Olema Pharmaceuticals, Inc. (OLMA)

Website

Price
Market cap
Next catalystDec 9, 2026OP-3136 — breast cancer monotherapy and endocrine combinations · Phase 1/2 dataCompany release ↗
Cash

Chart & Events

Candle interval

Core Clinical

Small molecule

Estrogen receptor (ER/ESR1)

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

OP-3136

Small molecule

KAT6

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

OP-3136

Small molecule

KAT6

PreINDP1P3FilingApproved
Upcoming / outlook

OP-3136

Small molecule

KAT6

PreINDP1P2P3FilingApproved

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

OP-3136

Small molecule

KAT6

PreINDP1P3FilingApproved
Upcoming / outlook

OP-3136

Small molecule

KAT6

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

Small molecule

Estrogen receptor (ER/ESR1)

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

Other pipelines

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Company funding outlook

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Source and basis

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

OLMA PR & News

PR & News

OLMA SEC archive